155 related articles for article (PubMed ID: 36266920)
1. NBDHEX re-sensitizes adriamycin-resistant breast cancer by inhibiting glutathione S-transferase pi.
Sha H; Zou R; Lu Y; Gan Y; Ma R; Feng J; Chen D
Cancer Med; 2023 Mar; 12(5):5833-5845. PubMed ID: 36266920
[TBL] [Abstract][Full Text] [Related]
2. In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung Cancer.
Sha H; Dong S; Yu C; Zou R; Zhu Y; Lu Y; Zhang J; Cao H; Chen D; Wu J; Feng J
J Cancer; 2020; 11(24):7216-7223. PubMed ID: 33193885
[TBL] [Abstract][Full Text] [Related]
3. The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma.
Tentori L; Dorio AS; Mazzon E; Muzi A; Sau A; Cuzzocrea S; Vernole P; Federici G; Caccuri AM; Graziani G
Eur J Cancer; 2011 May; 47(8):1219-30. PubMed ID: 21269821
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma.
Pellizzari Tregno F; Sau A; Pezzola S; Geroni C; Lapenta C; Spada M; Filomeni G; Bonanno E; Federici G; Caccuri AM
Eur J Cancer; 2009 Sep; 45(14):2606-17. PubMed ID: 19665369
[TBL] [Abstract][Full Text] [Related]
5. Glutathione S-Transferase Pi is Involved in the Growth of Mice.
Dong X; Rui B; Yin F; Chen D; Li L; Yin Z; Luo L
Chin J Physiol; 2018 Aug; 61(4):230-239. PubMed ID: 30139245
[TBL] [Abstract][Full Text] [Related]
6. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer.
Filomeni G; Turella P; Dupuis ML; Forini O; Ciriolo MR; Cianfriglia M; Pezzola S; Federici G; Caccuri AM
Mol Cancer Ther; 2008 Feb; 7(2):371-9. PubMed ID: 18281520
[TBL] [Abstract][Full Text] [Related]
7. A strong glutathione S-transferase inhibitor overcomes the P-glycoprotein-mediated resistance in tumor cells. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) triggers a caspase-dependent apoptosis in MDR1-expressing leukemia cells.
Turella P; Filomeni G; Dupuis ML; Ciriolo MR; Molinari A; De Maria F; Tombesi M; Cianfriglia M; Federici G; Ricci G; Caccuri AM
J Biol Chem; 2006 Aug; 281(33):23725-32. PubMed ID: 16769721
[TBL] [Abstract][Full Text] [Related]
8. 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol: a promising new anticancer compound.
Sha HH; Wang Z; Dong SC; Hu TM; Liu SW; Zhang JY; Wu Y; Ma R; Wu JZ; Chen D; Feng JF
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29358310
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases.
Federici L; Lo Sterzo C; Pezzola S; Di Matteo A; Scaloni F; Federici G; Caccuri AM
Cancer Res; 2009 Oct; 69(20):8025-34. PubMed ID: 19808963
[TBL] [Abstract][Full Text] [Related]
10. Glutathion S transferase pi indicates chemotherapy resistance in breast cancer.
Su F; Hu X; Jia W; Gong C; Song E; Hamar P
J Surg Res; 2003 Jul; 113(1):102-8. PubMed ID: 12943817
[TBL] [Abstract][Full Text] [Related]
11. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.
Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M
Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490
[TBL] [Abstract][Full Text] [Related]
12. Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy.
Pasello M; Manara MC; Michelacci F; Fanelli M; Hattinger CM; Nicoletti G; Landuzzi L; Lollini PL; Caccuri A; Picci P; Scotlandi K; Serra M
Anal Cell Pathol (Amst); 2011; 34(3):131-45. PubMed ID: 21673434
[TBL] [Abstract][Full Text] [Related]
13. The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells.
Ascione A; Cianfriglia M; Dupuis ML; Mallano A; Sau A; Pellizzari Tregno F; Pezzola S; Caccuri AM
Cancer Chemother Pharmacol; 2009 Jul; 64(2):419-24. PubMed ID: 19288261
[TBL] [Abstract][Full Text] [Related]
14. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio) Hexanol Inhibits Proliferation and Induces Apoptosis of Endometriosis by Regulating Glutathione S-Transferase Mu Class 4.
Liu W; Cheng L; Du Y; Liu X; Ma J; Yan L
Reprod Sci; 2023 Oct; 30(10):2945-2961. PubMed ID: 36928896
[TBL] [Abstract][Full Text] [Related]
15. DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo.
Zhang P; Zheng BB; Wang HY; Chen JH; Liu XY; Guo XL
J Pharm Pharmacol; 2014 Mar; 66(3):398-407. PubMed ID: 24533823
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol Derivatives as Glutathione Transferase Inhibitors with Favorable Selectivity and Tolerated Toxicity.
Liu Q; Liu Z; Hua W; Gou S
J Med Chem; 2021 Feb; 64(3):1701-1712. PubMed ID: 33529017
[TBL] [Abstract][Full Text] [Related]
17. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
18. A cisplatin-based platinum(IV) prodrug containing a glutathione s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer.
Chen H; Wang X; Gou S
J Inorg Biochem; 2019 Apr; 193():133-142. PubMed ID: 30731264
[TBL] [Abstract][Full Text] [Related]
19. Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines.
Sau A; Filomeni G; Pezzola S; D'Aguanno S; Tregno FP; Urbani A; Serra M; Pasello M; Picci P; Federici G; Caccuri AM
Mol Biosyst; 2012 Apr; 8(4):994-1006. PubMed ID: 22068640
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase P1-1 as a target for mesothelioma treatment.
De Luca A; Pellizzari Tregno F; Sau A; Pastore A; Palumbo C; Alama A; Cicconi R; Federici G; Caccuri AM
Cancer Sci; 2013 Feb; 104(2):223-30. PubMed ID: 23121163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]